| The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age (NCT03760458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-09-09 |
| Computer Aided Screening for Tuberculosis in Low Resource Environments (NCT04545164) | London School of Hygiene and Tropical Medicine | 2020-09-02 |
| HIV Treatment Adherence Dose Determination Trial (NCT04577313) | University of Connecticut | 2020-09-01 |
| Pregnancy in Women With HIV Infection (NCT04350554) | Carlos III Health Institute | 2020-09-01 |
| Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication (NCT04222283) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2020-08-17 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults (NCT04224701) | International AIDS Vaccine Initiative | 2020-08-01 |
| GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers (NCT04493684) | ViiV Healthcare | 2020-07-31 |
| Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants (NCT04484337) | ViiV Healthcare | 2020-07-31 |
| Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment (NCT03678181) | University of Pennsylvania | 2020-07-07 |
| Geriatric HIV Cohort in Sub Sahara Africa (NCT04313699) | Makerere University | 2020-07-01 |
| Vienna HIV Infection Via Sex Study (NCT05326061) | Medical University of Vienna | 2020-07-01 |
| HPV-Based Screen-and-Treat Demonstration Project in Lilongwe (NCT04092257) | UNC Lineberger Comprehensive Cancer Center | 2020-06-24 |
| HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance (NCT04334551) | Clinique du Quartier Latin | 2020-06-23 |
| Scaling up an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam: an Implementation Trial (NCT03952520) | University of North Carolina, Chapel Hill | 2020-06-10 |
| Design and Development of a Mobile App to Improve Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men (NCT04248790) | National Cheng Kung University | 2020-05-25 |
| COVID-19 Serology in People Living with HIV in Hong Kong (NCT05028881) | Chinese University of Hong Kong | 2020-05-16 |
| HIV-HEART Aging Study (NCT04330287) | University Hospital, Essen | 2020-05-11 |
| Immune Activation as a Cause of Insulin Resistance in Adults Living With HIV-1 on Effective Antiretroviral Therapy (NCT04028882) | University Hospital, Montpellier | 2020-03-03 |
| HIV Pre-exposure Prophylaxis Implementation Hong Kong Study (NCT04367688) | Chinese University of Hong Kong | 2020-03-01 |
| Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males (NCT04692077) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-02-19 |
| Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women (NCT04270773) | University Hospital Virgen de las Nieves | 2020-02-12 |
| Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP (NCT04050540) | University of Washington | 2020-02-05 |
| Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ (NCT04429061) | University of Alabama at Birmingham | 2020-02-01 |
| Workplace-based HIV Self-testing Among Men in Uganda (WISe-Men) (NCT04164433) | Makerere University | 2020-02-01 |
| Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy (NCT05168137) | Mahidol University | 2020-02-01 |
| HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM) (NCT03763942) | Emory University | 2020-01-28 |
| A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants (NCT04263142) | ViiV Healthcare | 2020-01-27 |
| Impart: Provider-Assisted HIV Partner Notification (NCT04155320) | University of Illinois at Chicago | 2020-01-27 |
| Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF) (NCT04054089) | Cristina Mussini | 2020-01-23 |
| Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App) (NCT03803683) | Rebecca Schnall, RN, MPH, PhD | 2020-01-21 |
| Enhancing Sexual Safety: Couples' Communication and HIV Testing Among YMSM (NCT04289116) | Florida State University | 2020-01-20 |
| Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults (NCT04177355) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-13 |
| Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy (NCT03965923) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-09 |
| Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services (NCT04155502) | Lisa A. Marsch | 2020-01-06 |
| HIV Infection And Evolvement of Atherosclerotic Plaque (NCT04810364) | Central Clinical Hospital of the Russian Academy of Sciences | 2020-01-05 |
| AmB Dose for Cryptococcal Meningitis (NCT04140461) | Shanghai Public Health Clinical Center | 2020-01-02 |
| Project Jumpstart for Improving PrEP Care of Continuum Outcomes (NCT04201327) | University of Connecticut | 2020-01-01 |
| Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS (NCT05786703) | Muhimbili University of Health and Allied Sciences | 2020-01-01 |
| HIV Indicator Diseases in Hospital and Primary Care (NCT05225493) | Erasmus Medical Center | 2020-01-01 |
| N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV (NCT04144335) | University of Minnesota | 2020-01-01 |
| Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 (NCT03739996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-31 |
| Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis (NCT03851588) | University of Cape Town | 2019-12-19 |
| Differentiated Service Delivery for Antiretroviral Therapy (NCT04383769) | Thai Red Cross AIDS Research Centre | 2019-12-15 |
| Safety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered Rectally (NCT04047420) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-11 |
| Body Composition Sub-study of the D2EFT Trial (NCT03675815) | Kirby Institute | 2019-12-05 |
| Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU ) (NCT04108728) | Nantes University Hospital | 2019-11-19 |
| Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women (NCT03564613) | ViiV Healthcare | 2019-11-18 |
| Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) (NCT04134767) | April M Young | 2019-11-15 |
| Mobile Enhanced Prevention Support for People Leaving Jail (NCT04036396) | University of California, Los Angeles | 2019-11-14 |
| Tushirikiane HIV-self Testing Intervention With Urban Refugee Youth in Kampala, Uganda (NCT04504097) | University of Toronto | 2019-11-13 |
| Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis (NCT03930654) | The University of Texas Health Science Center, Houston | 2019-11-13 |
| Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA) (NCT04021290) | ViiV Healthcare | 2019-11-11 |
| Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. (NCT04160455) | Centre Hospitalier Régional d'Orléans | 2019-11-07 |
| Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV Infection (NCT04240509) | The Miriam Hospital | 2019-11-01 |
| A Couples-based Intervention for Transgender Women and Their Partners (NCT04067661) | University of Michigan | 2019-11-01 |
| Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV (NCT04155294) | University of Oxford | 2019-10-28 |
| Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders (NCT05791851) | University of Maryland, Baltimore | 2019-10-23 |
| 2000 HIV Human Functional Genomics Partnership Program (NCT03994835) | Radboud University Medical Center | 2019-10-16 |
| Trans People Living With HIV Throughout Europe (NCT03922269) | Chelsea and Westminster NHS Foundation Trust | 2019-10-11 |
| Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs (NCT03695393) | Boston Medical Center | 2019-10-10 |
| A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection (NCT04076423) | Fundacion SEIMC-GESIDA | 2019-10-10 |
| A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants (NCT04128293) | ViiV Healthcare | 2019-10-08 |
| Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing Kit (NCT07488221) | University of North Carolina, Chapel Hill | 2019-10-08 |
| Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern US (NCT04097834) | University of North Carolina, Chapel Hill | 2019-10-07 |
| Vitamin E for NASH Treatment in HIV Infected Individuals (NCT03669133) | Indiana University | 2019-10-01 |
| Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study (NCT05674682) | Evandro Chagas National Institute of Infectious Disease | 2019-10-01 |
| Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs (NCT04034862) | University of Liege | 2019-10-01 |
| Skeletal Muscle Energetics and Fatiguability in Older Individuals (NCT04142047) | Johns Hopkins University | 2019-09-05 |
| Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants (NCT03934541) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-26 |
| Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART (NCT03787095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-13 |
| Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial (NCT03991013) | University of Cape Town | 2019-08-08 |
| Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe (NCT04048629) | Clinton Health Access Initiative Inc. | 2019-08-05 |
| Yathu Yathu: An Impact Evaluation of Community-based Peer-led Sexual and Reproductive Health Services (NCT04060420) | London School of Hygiene and Tropical Medicine | 2019-08-03 |
| HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention (NCT03465852) | Centers for Disease Control and Prevention | 2019-07-15 |
| Task Shifting to Treat Depression and HIV Medication Nonadherence in Low Resource Settings (NCT04018391) | King's College London | 2019-07-12 |
| Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) (NCT04001803) | ViiV Healthcare | 2019-07-08 |
| Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP) (NCT03996941) | BCN Checkpoint | 2019-07-05 |
| Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults (NCT03945981) | ViiV Healthcare | 2019-07-02 |
| Syndemics and Loss from the HIV Care Continuum in India - Intervention (NCT03966586) | Brigham and Women's Hospital | 2019-06-20 |
| T-cell Responses to Concurrent HIV and Herpesvirus Infections (NCT03996018) | St. Jude Children's Research Hospital | 2019-06-19 |
| Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent (NCT03984838) | ViiV Healthcare | 2019-06-17 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study (NCT03984812) | ViiV Healthcare | 2019-06-17 |
| Testing an Online Intervention to Improve Parents' Communication With Gay and Bisexual Sons About Sex and HIV (NCT04018573) | George Washington University | 2019-06-14 |
| Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive (NCT03984825) | ViiV Healthcare | 2019-06-13 |
| CCR5-modified CD4+ T Cells for HIV Infection (NCT03666871) | University of Cincinnati | 2019-06-12 |
| Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre (NCT03993093) | Singh, Ranjan Kumar, M.D. | 2019-06-01 |
| Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men (NCT03891407) | University of South Carolina | 2019-06-01 |
| A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells (NCT03856996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-23 |
| Home HIV Testing for Older Adults in South Africa (NCT04131465) | Harvard School of Public Health (HSPH) | 2019-05-15 |
| PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in Mexico (NCT03674983) | Brown University | 2019-05-15 |
| Frailty in People Living With HIV Aged 70 Years or More (NCT03958786) | ANRS, Emerging Infectious Diseases | 2019-05-15 |
| Dolutegravir Pediatric Liquid Formulation Study (NCT03921723) | ViiV Healthcare | 2019-05-07 |
| Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy (NCT03819114) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-05-06 |
| Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents (NCT03682848) | ViiV Healthcare | 2019-05-06 |
| Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women (NCT02949713) | University of Stellenbosch | 2019-05-02 |
| Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study (NCT03732625) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2019-05-01 |
| Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers (NCT03730311) | Viriom | 2019-05-01 |
| Peer Intervention Latino Immigrant MSM (NCT03922126) | University of Washington | 2019-05-01 |
| Adoptive Transfer of Haploidentical NK Cells and N-803 (NCT03899480) | University of Minnesota | 2019-05-01 |
| Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit (NCT06518213) | University Hospital for Infectious Diseases, Croatia | 2019-05-01 |